Coronary revascularization (ANGIO or CABG)

MESH PheWeb

I9_REVASC

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries None

Check pre-conditions, main-only, mode, ICD version None

Check minimum number of events None

Include endpoints

I9_ANGIO

I9_CABG

19747

I9_REVASC

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Coronary revascularization (ANGIO or CABG) based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	19151	4840	14311
Unadjusted prevalence (%)	6.21	2.79	10.60
Mean age at first event (years)	64.42	66.19	63.81

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	1.94 [1.69, 2.24]	3.6e-20	4655
15 years	0.01	1.44 [1.27, 1.63]	1.3e-8	2538
5 years	0.00	2.03 [1.82, 2.27]	1.0e-37	1048
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: I9_REVASC – Coronary revascularization (ANGIO or CABG)
GWS hits: 48

Survival analyses between endpoints

↥

Plot

before Coronary revascularization (ANGIO or CABG)
after Coronary revascularization (ANGIO or CABG)

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Coronary revascularization (ANGIO or CABG)

↥